Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
Condition(s):Polymyalgia RheumaticaLast Updated:March 26, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Polymyalgia RheumaticaLast Updated:March 26, 2024Recruiting
Condition(s):Polymyalgia Rheumatica (PMR)Last Updated:January 17, 2018Completed
Condition(s):Polymyalgia RheumaticaLast Updated:December 4, 2020Completed
Condition(s):Giant Cell Arteritis; Polymyalgia RheumaticaLast Updated:December 1, 2023Recruiting
Condition(s):Horton DiseaseLast Updated:November 17, 2021Unknown status
Condition(s):Giant Cell Arteritis; Tomography, Optical CoherenceLast Updated:February 15, 2023Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:November 22, 2023Recruiting
Condition(s):Giant Cell Arteritis; VasculitisLast Updated:October 24, 2023Completed
Condition(s):Polymyalgia RheumaticaLast Updated:May 20, 2022Active, not recruiting
Condition(s):Polymyalgia Rheumatica; Effect of Drug; Safety IssuesLast Updated:September 15, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.